Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386867 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
A NA study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT00386867 is a NA study that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,200 participants.
The verdict
NCT00386867, a NA study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.
Interventions
- DRUG 800 mcg misoprostol via oral or buccal administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386867
The ClinicalTrials.gov registry entry for NCT00386867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 800 mcg misoprostol via oral or buccal administration is the first listed.
NCT00386867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386867 about?
NCT00386867 is a clinical study titled "A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP". This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.
What is the current status of trial NCT00386867?
This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2006-10. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00386867?
The interventions under investigation include: 800 mcg misoprostol via oral or buccal administration (DRUG).
Who is sponsoring clinical trial NCT00386867?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.